Results 221 to 230 of about 138,819 (251)
Some of the next articles are maybe not open access.
Cutaneous allodynia in patients with episodic migraine
Neurological Sciences, 2012Cutaneous allodynia may be observed in patients with migraine and this reflects the central sensitization of the trigeminal neurons. We aimed to investigate the frequency of cutaneous allodynia in patients with episodic migraine and to compare clinical characteristics of migraine patients with and without allodynia.
Hayat, Güven +2 more
openaire +2 more sources
The Episodic Syndromes That Maybe Associated with Migraines
Seminars in Pediatric Neurology, 2016The "childhood periodic syndromes" have been renamed "the episodic syndromes that maybe associated with migraines". These syndromes were initially considered precursors of migraines that only occurred in childhood; however recent literature suggests that the episodic syndromes can occur in adults with known migraine and does not necessarily present as ...
Diana, Lebron, Elza, Vasconcellos
openaire +2 more sources
Episodic Vertigo in Basilar Artery Migraine
Otolaryngology–Head and Neck Surgery, 1987Vestibular symptoms commonly occur in migraine, and episodic vertigo is most frequently seen. Auditory symptoms also occur, but are less common. When Bickerstaff8 described basilar artery migraine in 1961, he postulated that the many different symptoms were caused by basilar artery ischemia.
L A, Harker, C H, Rassekh
openaire +2 more sources
Fremanezumab for the prevention of chronic and episodic migraine
Drugs of Today, 2019On September 15, 2018, the U.S. Food and Drug Administration (FDA) approved subcutaneous fremanezumab, a calcitonin gene-related peptide (CGRP) monoclonal antibody, for the treatment of episodic and chronic migraine in adults, with two recommended dosages: 225 mg monthly or 675 mg every 3 months.
L, Lionetto +3 more
openaire +2 more sources
Episodic syndromes of childhood associated with migraine
Current Opinion in Neurology, 2018Purpose of review This review covers recent advances in our understanding of episodic syndromes that may be associated with migraine in children and adolescents, as well as what is known about the treatment of these disorders. Recent findings
openaire +2 more sources
First Episode of Hemiplegic Migraine
Pediatric Neurology, 2017Stephanie, Ahrens, Adam, Ostendorf
openaire +2 more sources
Fremanezumab in Children and Adolescents with Episodic Migraine
New England Journal of MedicineFremanezumab, a humanized monoclonal antibody that selectively targets calcitonin gene-related peptide, is approved for the prevention of migraine in adults. Evidence from randomized, controlled trials in children and adolescents is needed.We randomly assigned participants 6 to 17 years of age with a diagnosis of episodic migraine (defined as migraine ...
Andrew D, Hershey +10 more
openaire +2 more sources